This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

Interview with Barry Straube, MD, Acting Chief Medical Officer for CMS: Coverage Decision Process Improves, but Cost-Controlling Measures Loom

Some changes in the Medicare program brought about by passage of the Medicare Modernization Act (MMA) are familiar to oncologists, especially the reduction in reimbursement for chemotherapy drugs. But other major changes the act brought are positive ones for oncologists and their patients, according to Barry Straube, MD, acting chief medical officer for the Centers for Medicare and Medicaid Services (CMS). As a result of the MMA and a policy initiative, the coverage decision process is far more transparent and speedy, and access to care for emerging therapies and technologies is improving.

Today, coverage decisions remain unaffected by economic considerations. . . . [Click for More]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?